Thailand buys 50,000 courses of Pfizer anti-viral drug Paxlovid


BANGKOK (The Nation/Asia News Network): The Medical Services Department on Thursday (March 24) signed a contract to purchase 50,000 treatment courses of Paxlovid drug with Pfizer Thailand for Covid-19 patients in risk groups.

Department director-general Somsak Akkasilp took part in the online contract signing with Deborah Seifert, country manager of Pfizer Thailand and Indochina.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Thailand , covid-19 , anti-viral , Pfizer , drug , paxlovid

Next In Aseanplus News

US travel magazine names Vietnam's Phu Quoc island one of top trending destinations for 2026
Thai Customs set to tighten free zone rules, raise per-item fines to curb false declarations
MACC nabs Tan Sri, company director over alleged RM300mil investment scam
Oil slips as investors assess supply outlook, US stock build
Japan pauses restart of world's biggest nuclear plant
AirAsia X targets up to US$600mil debt restructuring after combining airlines
Squid Game’s Park Hae-soo rides another wave of global fame
World’s oldest cave art discovered in Indonesia
70 travellers caught for evading taxes, duties in week-long operation at Singapore checkpoints
‘I would have slapped them’: Former general turned MP on ‘yeye’ culture

Others Also Read